Comparative efficacy and safety of pharmacologic therapies for metabolic dysfunction-associated steatotic liver disease over 24 weeks in reducing liver steatosis and fibrosis: a network meta-analysis
Zhong J, Cai Z, Zhu G, Zhang J
Diabetes Obes Metab. Pub. online 10 Apr 2025.
Leggi